Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

Ruxolitinib, used in children with steroid-refractory acute graft-versus-host (GVH) disease, is currently commercially available only as a tablet adult dosage. For the paediatric population, an oral liquid would be an adapted dosage formulation. The aim of this study was to develop ruxolitinib compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinterlang, Mélanie, Sebti, Maria, Cotteret, Camille, Vidal, Fabrice, Neven, Bénédicte, Cisternino, Salvatore, Schlatter, Joël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184215/
https://www.ncbi.nlm.nih.gov/pubmed/35694327
http://dx.doi.org/10.1155/2022/1931118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184215/
https://www.ncbi.nlm.nih.gov/pubmed/35694327
http://dx.doi.org/10.1155/2022/1931118

Ejemplares similares